Insider Holders & Insider Ownership - Intellia Therapeutics Inc. (NTLA)

List of insiders holdings for Intellia Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
Haurwitz Rachel E.
Director
10% Owner
2016-05-11 18:40:060
5,593,846
5,593,846Form 4
Novartis Institutes for BioMedical Research Inc.
NOVARTIS AG
10% Owner
2021-01-22 16:59:182,176,148
0
2,176,148Form 13D
ORBIMED ADVISORS LLC
OrbiMed Capital GP V LLC
OrbiMed Global Healthcare GP LLC
ISALY SAMUEL D
Director
2018-02-16 13:25:102,113,000
0
2,113,000Form 13D
Caribou Therapeutics Holdco LLC
Caribou Biosciences Inc.
10% Owner
2019-03-25 14:19:401,807,841
0
1,807,841Form 13G
Caribou Biosciences Inc.
10% Owner
2019-03-25 14:19:401,807,841
0
1,807,841Form 13G
Atlas Venture Fund IX L.P.
Atlas Venture Associates IX L.P.
Atlas Venture Associates IX LLC
10% Owner
2019-02-08 06:02:111,615,321
0
1,615,321Form 13G
LEONARD JOHN M
President and CEO
2024-03-05 16:10:121,124,001
58,415
1,182,416Form 4
BAKER BROS. ADVISORS LP
BAKER FELIX
BAKER JULIAN
Baker Bros. Advisors (GP) LLC
Former 10% owner
2016-05-11 16:25:530
976,214
976,214Form 4
Temasek Holdings (Private) Ltd
Fullerton Management Pte Ltd
Temasek Life Sciences Private Ltd
TLS Beta Pte. Ltd.
10% Owner
2016-05-13 06:15:190
790,527
790,527Form 4
Foresite Capital Management III LLC
Foresite Capital Fund III L.P.
Tananbaum James B.
10% Owner
2016-05-05 18:33:040
613,688
613,688Form 3
Rivera Jose E
EVP, General Counsel
2021-04-02 20:42:02287,594
262,210
549,804Form 4
Bermingham Nessan
President & CEO
2017-12-14 16:07:28292,500
0
292,500Form 4
Srivastava Sapna
Chief Financial & Stategy Offr
2016-05-05 18:38:24291,551
0
291,551Form 3
Bell Graeme
EVP, Chief Financial Officer
2018-03-30 10:20:51223,400
0
223,400Form 4
Lebwohl David
EVP, Chief Medical Officer
2024-03-05 16:10:10148,928
0
148,928Form 4
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
2024-03-05 16:10:23136,687
0
136,687Form 4
BASTA JAMES
EVP, General Counsel
2024-03-05 16:10:22128,323
0
128,323Form 4
Goddard Glenn
EVP, Chief Financial Officer
2024-03-05 16:10:07110,529
0
110,529Form 4
Hicks Derek
EVP, Chief Business Officer
2024-03-05 16:10:17108,801
0
108,801Form 4
SCHIERMEIER ANDREW
EVP, Chief Operating Officer
2021-03-05 17:53:1591,875
0
91,875Form 4
Clark Eliana
EVP, Chief Technical Officer
2024-07-03 13:15:0471,470
0
71,470Form 4
Cohen Fred E
Director
2024-06-14 16:19:2960,968
0
60,968Form 4
Barnes Thomas M.
SVP, R&D eXtellia
2017-01-10 20:09:1950,500
0
50,500Form 4
Dube Michael P
VP, PAO and Interim PFO
2024-07-03 13:15:0349,024
0
49,024Form 4
CHASE WILLIAM J
Director
2024-06-14 16:16:4138,208
0
38,208Form 4
Slaoui Moncef
Director
2017-07-25 16:47:2138,000
0
38,000Form 4
Keresty Georgia
Director
2024-06-14 16:21:0335,398
0
35,398Form 4
Bhanji Muna
Director
2024-06-14 16:18:0131,248
0
31,248Form 4
GOODMAN JESSE
Director
2024-06-14 16:20:4930,968
0
30,968Form 4
Morrissey David V
SVP, Platform & Delivery Tech
2017-01-10 20:11:1230,000
0
30,000Form 4
Heifner Nicole
SVP, Accounting
2017-01-10 20:12:3628,500
0
28,500Form 4
DORSA CAROLINE
Director
2022-06-16 18:26:4420,389
0
20,389Form 4
HAYES JOHN T.
See Remarks
2018-08-10 16:44:0819,925
0
19,925Form 3
GORDON CARL L
Director
2017-05-19 17:10:2819,000
0
19,000Form 4
Crowley John F
Director
2023-06-16 16:26:5818,189
0
18,189Form 4
Verwiel Frank
Director
2024-06-20 17:00:4317,948
0
17,948Form 4
FORMELA JEAN FRANCOIS
Director
2022-06-16 18:33:3614,979
0
14,979Form 4
KARSEN PERRY A
Director
2020-12-18 16:29:065000
0
5000Form 4
Goff Brian
Director
2024-06-17 17:15:550
0
0Form 3